Citadel Advisors »

Lava Therapeutics Nv shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $178k 53k 3.33
2023-12-31 $34k 22k 1.58
2023-03-31 $46k 28k 1.66
2021-06-30 $691k 62k 11.17
2021-03-31 $918k 60k 15.19

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Lava Therapeutics Nv

Redmile Group
Bruce & Co
Sphera Funds Management
Walleye Trading Advisors
Falcon Edge Capital
Two Sigma Investments
Pnc Financial Services
Citadel Advisors
Millennium Management
Schonfeld Strategic Advisors
Susquehanna International
Two Sigma Advisers
Bank of America Corporation
Pathway Financial Advisors
Two Sigma Securities

View all funds holding Lava Therapeutics Nv